Back to Search
CHRISTA BORGMAN, MD
MD
Pediatrics Physician
NPI: 1598179624Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
036142649(IL)277045(MA)
Research & Publications (7)
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.
PMID 19336729·Cancer Prev Res (Phila)·2009
7-preclinical
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).
PMID 19079597·PLoS One·2008
7-preclinical
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
PMID 18632637·Cancer Res·2008
7-preclinical
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
PMID 17613438·Cancer Cell·2007
7-preclinical
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272.
PMID 17311002·Oncogene·2007
8-other
Activation of a caspase-dependent oxidative damage response mediates TGFbeta1 apoptosis in rat hepatocytes.
PMID 12782012·Exp Mol Pathol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 55 FRUIT ST
BOSTON, MA 02114 - Phone
- (617) 726-2000
Quick Facts
- NPI
- 1598179624
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 7
Are you this provider?
Claim Your Profile